BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20672287)

  • 1. Editorial: a call for ethical regulation of genetically created organisms (GCOs) beyond GMOs.
    Lee SY
    Biotechnol J; 2010 Aug; 5(8):791. PubMed ID: 20672287
    [No Abstract]   [Full Text] [Related]  

  • 2. New technology ethic.
    Macer D
    Taiwan Yi Xue Ren Wen Xue Kan; 2001 Oct; 2(1-2):41-7. PubMed ID: 15011655
    [No Abstract]   [Full Text] [Related]  

  • 3. New Zealand Bioethics Conference February 2004: emerging biotechnologies: ethics and regulation.
    Evans D
    N Z Bioeth J; 2004 Feb; 5(1):16-21. PubMed ID: 15597488
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioethics and health law in New Zealand: bioethics commentary.
    Pickering N
    N Z Bioeth J; 2002 Feb; 3(1):10-3. PubMed ID: 15587483
    [No Abstract]   [Full Text] [Related]  

  • 5. The Cartagena protocol and GMOs.
    Pythoud F
    Nat Biotechnol; 2004 Nov; 22(11):1347-8. PubMed ID: 15529146
    [No Abstract]   [Full Text] [Related]  

  • 6. Biotech's defining moments.
    Miller HI
    Trends Biotechnol; 2007 Feb; 25(2):56-9. PubMed ID: 17173993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes of the public and scientists to biotechnology in Japan at the start of 2000.
    Ng MA; Takeda C; Watanabe T; Macer D
    Eubios J Asian Int Bioeth; 2000 Jul; 10(4):106-13. PubMed ID: 16273712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European Directive on the Legal Protection of Biotechnological Inventions: scope, status and controversies in a nutshell.
    Hakki MM
    E Law; 2004 Mar; 11(1):E4. PubMed ID: 16903025
    [No Abstract]   [Full Text] [Related]  

  • 9. Biotechnology and the creation of ethics.
    Coletta RR
    McGeorge Law Rev; 2000; 32(1):89-110. PubMed ID: 16523579
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic engineering: unnatural selection.
    Snow A
    Nature; 2003 Aug; 424(6949):619. PubMed ID: 12904767
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation of genetically modified organisms (GMOs) in the European Union: principles of risk assessment.
    Anadón A; Roda L; Martínez-Larrañaga MR
    Vet Hum Toxicol; 2004 Dec; 46(6):340-1. PubMed ID: 15587259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recipe for disaster.
    Nat Biotechnol; 2003 May; 21(5):465. PubMed ID: 12721554
    [No Abstract]   [Full Text] [Related]  

  • 13. Intellectual property, genetically modified crops and bioethics.
    Adcock M
    Biotechnol J; 2007 Sep; 2(9):1088-92. PubMed ID: 17703487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Italy employs further GMO delay tactics.
    Meldolesi A
    Nat Biotechnol; 2003 Apr; 21(4):346. PubMed ID: 12665808
    [No Abstract]   [Full Text] [Related]  

  • 15. [The critical scientists' voice].
    Lewgoy F
    Hist Cienc Saude Manguinhos; 2000; 7(2):503-8. PubMed ID: 16683329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Swiss 'dignity' law is threat to plant biology.
    Abbott A
    Nature; 2008 Apr; 452(7190):919. PubMed ID: 18441543
    [No Abstract]   [Full Text] [Related]  

  • 17. USDA scrutinizes GM organism regulations.
    Fox JL
    Nat Biotechnol; 2004 Mar; 22(3):254-5. PubMed ID: 14990936
    [No Abstract]   [Full Text] [Related]  

  • 18. The science and politics of plant biotechnology--a personal perspective.
    Vasil IK
    Nat Biotechnol; 2003 Aug; 21(8):849-51. PubMed ID: 12894193
    [No Abstract]   [Full Text] [Related]  

  • 19. Current ethical issues in synthetic biology: where should we go from here?
    Newson AJ
    Account Res; 2011 May; 18(3):181-93. PubMed ID: 21574073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concern about Japan's unclear biotech regulations.
    Watanabe KN
    Nature; 2003 Feb; 421(6924):689. PubMed ID: 12610594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.